Clover Biopharmaceuticals, Ltd. (2197.HK)
HKD 0.26
(0.0%)
HKD 0.26
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 334.45 Million CNY | -5.62% |
| 2022 | 354.36 Million CNY | 421.74% |
| 2021 | 67.92 Million CNY | 204.36% |
| 2020 | 22.31 Million CNY | 79.17% |
| 2019 | 12.45 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 212.94 Million CNY | -36.33% |
| 2024 Q2 | 212.94 Million CNY | 8.52% |
| 2023 Q4 | 334.45 Million CNY | 5.87% |
| 2023 FY | 334.45 Million CNY | -5.62% |
| 2023 Q3 | 315.91 Million CNY | -30.71% |
| 2023 Q2 | 455.94 Million CNY | 5.52% |
| 2023 Q1 | 432.1 Million CNY | 21.94% |
| 2022 Q2 | 80.21 Million CNY | 48.2% |
| 2022 Q1 | 54.12 Million CNY | -20.31% |
| 2022 FY | 354.36 Million CNY | 421.74% |
| 2022 Q4 | 354.36 Million CNY | 7.13% |
| 2022 Q3 | 330.79 Million CNY | 312.38% |
| 2021 FY | 67.92 Million CNY | 204.36% |
| 2021 Q1 | 29.09 Million CNY | 0.0% |
| 2021 Q3 | 46.44 Million CNY | 0.0% |
| 2021 Q4 | 67.92 Million CNY | 46.25% |
| 2020 FY | 22.31 Million CNY | 79.17% |
| 2019 FY | 12.45 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -532.627% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 94.361% |